Cyclosporin derivatives for treating ocular and dermal diseases and conditions

Details for Australian Patent Application No. 2009268549 (hide)

Owner Allergan, Inc.

Inventors Garst, Michael E.

Agent Davies Collison Cave

Pub. Number AU-A-2009268549

PCT Pub. Number WO2010/006117

Priority 61/134,510 10.07.08 US

Filing date 9 July 2009

Wipo publication date 14 January 2010

International Classifications

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 27/00 (2006.01) Drugs for disorders of the senses

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/006117 Priority application(s): WO2010/006117

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009268557-2-methylene-19,26-dinor-(20R,22E,25R )-vitamin D analogs

2009268547-Pharmaceutical compounds as cytotoxic agents and the use thereof